{"count": 3, "results": [{"_id": "28525374", "pmid": 28525374, "pmcid": "PMC5542201", "title": "The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)", "journal": "Oncotarget", "authors": ["Suzuki Y", "Enokido Y", "Yamada K", "Inaba M", "Kuwata K", "Hanada N", "Morishita T", "Mizuno S", "Wakamatsu N"], "date": "2017-07-11T00:00:00Z", "doi": "10.18632/oncotarget.17566", "meta_date_publication": "2017 Jul 11", "meta_volume": "8", "meta_issue": "28", "meta_pages": "45470-45483", "score": 50049.543, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also effectively suppressed the growth of both @<m>DISEASE_Simpson_Golabi_Behmel_syndrome</m> @DISEASE_MESH:C537340 @@@PROS@@@ fibroblast lines, which had different frequency of mosaic mutations. ", "citations": {"NLM": "Suzuki Y, Enokido Y, Yamada K, Inaba M, Kuwata K, Hanada N, Morishita T, Mizuno S, Wakamatsu N. The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS) Oncotarget. 2017 Jul 11;8(28):45470-45483. PMID: 28525374", "BibTeX": "@article{28525374, title={The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)}, author={Suzuki Y and Enokido Y and Yamada K and Inaba M and Kuwata K and Hanada N and Morishita T and Mizuno S and Wakamatsu N}, journal={Oncotarget}, volume={8}, number={28}, pages={45470-45483}}"}}, {"_id": "24243637", "pmid": 24243637, "title": "Proinflammatory cytokine induction of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in human adipocytes is mediated by MEK, C/EBPbeta, and NF-kappaB/RelA.", "journal": "J Clin Endocrinol Metab", "authors": ["Esteves CL", "Kelly V", "Breton A", "Taylor AI", "West CC", "Donadeu FX", "Péault B", "Seckl JR", "Chapman KE"], "date": "2014-01-01T00:00:00Z", "doi": "10.1210/jc.2013-1708", "meta_date_publication": "2014 Jan", "meta_volume": "99", "meta_issue": "1", "meta_pages": "E160-8", "score": 50046.277, "text_hl": "Treatment of adipocyte fractions or @<m>DISEASE_Simpson_Golabi_Behmel_syndrome</m> @DISEASE_MESH:C537340 @@@SGBS@@@ adipocytes with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@acetylsalicylic acid@@@, which target @GENE_CEBPB @GENE_1051 @@@C/EBPbeta@@@ and @GENE_NFKB1 @GENE_4790 @@@NF-kappaB@@@/@GENE_RELA @GENE_5970 @@@RelA@@@ signaling, attenuated the @GENE_IL1A @GENE_3552 @@@IL-1alpha@@@ induction of @GENE_HSD11B1 @GENE_3290;26871 @@@11beta-HSD1@@@ (P<=.002). ", "citations": {"NLM": "Esteves CL, Kelly V, Breton A, Taylor AI, West CC, Donadeu FX, Péault B, Seckl JR, Chapman KE. Proinflammatory cytokine induction of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in human adipocytes is mediated by MEK, C/EBPbeta, and NF-kappaB/RelA. J Clin Endocrinol Metab. 2014 Jan;99(1):E160-8. PMID: 24243637", "BibTeX": "@article{24243637, title={Proinflammatory cytokine induction of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in human adipocytes is mediated by MEK, C/EBPbeta, and NF-kappaB/RelA.}, author={Esteves CL and Kelly V and Breton A and Taylor AI and West CC and Donadeu FX and Péault B and Seckl JR and Chapman KE}, journal={J Clin Endocrinol Metab}, volume={99}, number={1}, pages={E160-8}}"}}, {"_id": "27459533", "pmid": 27459533, "pmcid": "PMC5052341", "title": "Metformin Increases Cortisol Regeneration by 11betaHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus", "journal": "J Clin Endocrinol Metab", "authors": ["Anderson AJ", "Andrew R", "Homer NZ", "Jones GC", "Smith K", "Livingstone DE", "Walker BR", "Stimson RH"], "date": "2016-10-01T00:00:00Z", "doi": "10.1210/jc.2016-2069", "meta_date_publication": "2016 Oct", "meta_volume": "101", "meta_issue": "10", "meta_pages": "3787-3793", "score": 50039.53, "text_hl": "Oral @CHEMICAL_Cortisone @CHEMICAL_MESH:D003348 @@@cortisone@@@ was given to measure hepatic @GENE_HSD11B1 @GENE_3290 @@@11betaHSD1@@@ activity in the ODM group. The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @GENE_HSD11B1 @GENE_3290 @@@11betaHSD1@@@ was also assessed in @SPECIES_9606 @@@human@@@ hepatocytes and @<m>DISEASE_Simpson_Golabi_Behmel_syndrome</m> @DISEASE_MESH:C537340 @@@Simpson-Golabi-Behmel syndrome@@@ adipocytes.", "citations": {"NLM": "Anderson AJ, Andrew R, Homer NZ, Jones GC, Smith K, Livingstone DE, Walker BR, Stimson RH. Metformin Increases Cortisol Regeneration by 11betaHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus J Clin Endocrinol Metab. 2016 Oct;101(10):3787-3793. PMID: 27459533", "BibTeX": "@article{27459533, title={Metformin Increases Cortisol Regeneration by 11betaHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus}, author={Anderson AJ and Andrew R and Homer NZ and Jones GC and Smith K and Livingstone DE and Walker BR and Stimson RH}, journal={J Clin Endocrinol Metab}, volume={101}, number={10}, pages={3787-3793}}"}}]}